These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4658109)

  • 21. [Results obtained with pyridinocarbamate in the treatment of atherosclerosis in different parta of the body].
    Bronstein J; Galeano JC; Soutric JL; Steinman J; Novaro Hueyo JA
    Prensa Med Argent; 1969 Oct; 56(32):1543-9. PubMed ID: 5405011
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recent acquisitions in the field of arterial hypertension and cerebral atherosclerosis].
    Ravina A
    Presse Med (1893); 1966 Jul 9-16; 74(34):1765-6. PubMed ID: 5328564
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of unithiol in mercury poisoning].
    Fesenko IT
    Vrach Delo; 1969 Oct; 10():85-7. PubMed ID: 5366825
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic use of a combination containing calcium, vitamins, pantethine and carnitine in convalescence states in childhood].
    Canonaco F; Sala R
    Clin Ter; 1985 Oct; 115(2):95-9. PubMed ID: 4075759
    [No Abstract]   [Full Text] [Related]  

  • 26. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA
    Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the treatment of cerebral and peripheral arterial obliterating vascular disorders with Tebonin].
    Gau HP
    Arztl Forsch; 1969; 23(3):103-11. PubMed ID: 5819754
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experiences with the preparation Seniosan].
    Pernhaupt G
    Med Monatsschr; 1969 Oct; 23(10):461-4. PubMed ID: 4242114
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug therapy of cerebral arteriosclerosis in the senile age].
    Mankovsky N; Mints A
    G Gerontol; 1972 Jan; 20(1):42-9. PubMed ID: 5023587
    [No Abstract]   [Full Text] [Related]  

  • 30. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in coagulographic indices of patients with cerebral atherosclerosis complicated by mental disorders during the treatment process].
    Pavlova SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(7):1016-9. PubMed ID: 7415719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical manifestations and treatment of early cerebral atherosclerosis].
    Mints AIa
    Klin Med (Mosk); 1981 Sep; 59(9):25-8. PubMed ID: 7311425
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of ribonucleic acid in cerebral atherosclerosis].
    Belonog RP; Mashek IuA
    Vrach Delo; 1974 Oct; 0(10):58-61. PubMed ID: 4417222
    [No Abstract]   [Full Text] [Related]  

  • 34. [Multiple treatment and multimorbidity in the aged. A multiple medication study].
    Frankl R; Schmidt-Modrow G
    ZFA (Stuttgart); 1977 Feb; 53(4):225-9. PubMed ID: 848094
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of cerebral arteriosclerosis with heparin electrophoresis].
    Man'kovskiĭ NB; Mints AIa; Kalmykova OG; Pavlikova RN
    Vrach Delo; 1974; 4():78-83. PubMed ID: 4831873
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of thyroidin in combination with vitamins C, B-6 and B-12 in cerebral arteriosclerosis].
    Komorovskaia IaM
    Vrach Delo; 1965 May; 5():54-9. PubMed ID: 5854497
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of pyridinocarbamate in chronic cerebral arteriosclerosis].
    de Oliveira JM
    Hospital (Rio J); 1970 Feb; 77(2):441-50. PubMed ID: 4393836
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative evaluation of the therapeutic effectiveness of drugs of different mechanisms of action in cerebral atherosclerosis].
    Sobczyk W
    Neurol Neurochir Pol; 1982; 16(4):245-60. PubMed ID: 7145012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of cerebrolysin in patients with cerebral arteriosclerosis].
    Zhovnir IK; Brozhik NS; Krotiuk LN
    Vrach Delo; 1973 Nov; 11():109-11. PubMed ID: 4786906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.